✦ LIBER ✦

New therapeutic targets to develop molecules active in drug-resistant epilepsies

✍ Scribed by Mounia SidAhmed-Mezi; René Pumain; Jacques Louvel; Pierre Sokoloff; Jacques Laschet

Book ID: 109112737
Publisher: Wiley (Blackwell Publishing)
Year: 2010
Tongue: English
Weight: 197 KB
Volume: 51
Category: Article
ISSN: 0013-9580
DOI: 10.1111/j.1528-1167.2010.02608.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A human systems biology approach to disc

A human systems biology approach to discover new drug targets in epilepsy

✍ Jeffery A. Loeb 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 322 KB

From old organisms to new molecules: int

From old organisms to new molecules: integrative biology and therapeutic targets in accelerated human ageing

✍ L. S. Cox; R. G. A. Faragher 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 579 KB

A guide to drug discovery: Trends in dev

A guide to drug discovery: Trends in development and approval times for new therapeutics in the United States

✍ Reichert, Janice M. 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 216 KB

High antineoplastic activity of new hete

High antineoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs

✍ Hermann Lage; Esin Aki-Sener; Ismail Yalcin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 237 KB

## Abstract Twenty previously synthesized fused heterocyclic DNA‐topoisomerase II (Topo II)‐inhibiting compounds were investigated for their potential efficacy in various human cancer cell lines that were derived from different tumor entities. Moreover, different multidrug‐resistant variants of the

Notch signaling as a therapeutic target

Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents

✍ Nickoloff, Brian J; Osborne, Barbara A; Miele, Lucio 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 324 KB